2731 - 2740 of 9145 Results
Title
Year
- New evidence on the clinical, genetic, and biochemical bases of GBA1-Parkinson's disease: prospects for treatment2026RESTRICTEDTitle: New evidence on the clinical, genetic, and biochemical bases of GBA1-Parkinson's disease: prospects for treatmentJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 25Issue #: 6Start Page: 602End Page: 614Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(26)00090-6Citation Count: 2
-
OPENTitle: Parkinson's disease genetics across diverse ancestries: an observational genetic study of causal and risk variants with translational implicationsJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 25Issue #: 8Start Page: 741End Page: 754Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/s1474-4422(26)00198-5Best OA location URL: https://doi.org/10.1016/s1474-4422(26)00198-5Citation Count: 1
- Protocol for SEC-based isolation and characterization of human plasma-derived extracellular vesicles2026OPENTitle: Protocol for SEC-based isolation and characterization of human plasma-derived extracellular vesiclesJournal Name: STAR ProtocolsPublisher: Elsevier BVVol: 7Issue #: 3Start Page: 104735End Page: 104735Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.xpro.2026.104735Best OA location URL: https://doi.org/10.1016/j.xpro.2026.104735Citation Count: 0
- Preclinical evaluation of nitrated α-synuclein-specific CAR-Treg therapy in Parkinson’s disease2026OPENTitle: Preclinical evaluation of nitrated α-synuclein-specific CAR-Treg therapy in Parkinson’s diseaseJournal Name: Cell Reports MedicinePublisher: Elsevier BVVol: 7Issue #: 9Start Page: 102983End Page: 102983Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.xcrm.2026.102983Best OA location URL: https://doi.org/10.1016/j.xcrm.2026.102983Citation Count: 0
-
OPENTitle: An automated workflow for quantifying the formation of synuclein aggregates in human dopaminergic neuronsJournal Name: MethodsPublisher: Elsevier BVVol: 254Issue #:Start Page: 29End Page: 41Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ymeth.2026.06.005Best OA location URL: https://doi.org/10.1016/j.ymeth.2026.06.005Citation Count: 0
- Protocol for classifying cellular senescence from single-cell and single-nucleus RNA sequencing data2026OPENTitle: Protocol for classifying cellular senescence from single-cell and single-nucleus RNA sequencing dataJournal Name: STAR ProtocolsPublisher: Elsevier BVVol: 7Issue #: 3Start Page: 104724End Page: 104724Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.xpro.2026.104724Best OA location URL: https://doi.org/10.1016/j.xpro.2026.104724Citation Count: 0
- Exploring new uses for existing drugs: innovative mechanisms to fund independent clinical research2021OPENTitle: Exploring new uses for existing drugs: innovative mechanisms to fund independent clinical researchJournal Name: TrialsPublisher: Springer Science and Business Media LLCVol: 22Issue #: 1Start Page: 322End Page: 322Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13063-021-05273-xBest OA location URL: https://trialsjournal.biomedcentral.com/counter/pdf/10.1186/s13063-021-05273-xCitation Count: 45
-
OPENTitle: Incidence and Progression of Rapid Eye Movement Behavior Disorder in Early Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 4Start Page: 534End Page: 540Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.13168Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/134137Citation Count: 30
-
OPENTitle: Plasma phosphorylated tau217 discordance with amyloid status in an ethnically diverse mixed memory clinic cohortJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 488Issue #:Start Page: 126057End Page: 126057Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.jns.2026.126057Best OA location URL: https://www.jns-journal.com/article/S0022-510X(26)00339-4/pdfCitation Count: 1
-
OPENTitle: Paratonia in Advanced Dementia: Deconstructing Scientific, Regulatory, and Health System Barriers to Botulinum Toxin A (BoNT-A) Treatment of Involuntary Muscle ResistanceJournal Name: Journal of the American Medical Directors AssociationPublisher: Elsevier BVVol: 27Issue #: 7Start Page: 106285End Page: 106285Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.jamda.2026.106285Best OA location URL: https://www.jamda.com/article/S1525-8610(26)00175-1/pdfCitation Count: 0